Netherlands-based biopharmaceutical company argenx SE said it signed a deal with Cilag GmbH International, an affiliate of Johnson & Johnson's Janssen Pharmaceutical Companies unit, to develop its Cusatuzumab drug in certain types of cancer.
Dutch firm argenx, J&J affiliate to collaborate on cancer therapy
![Dutch firm argenx, J&J affiliate to collaborate on cancer therapy]()
Reviewed by jenisht
on
December 03, 2018
Rating:
No comments: